1-(4-Chlorobenzoyl)-1H-1,2,3-benzotriazole, 95.0%, 1g

3-(tert-Butoxycarbonylamino)pyrrolidine>98.0%(GC)(T)25g

4-chloro-5-ethyl-2,6-dimethylpyrimidine, 95.0%, 250mg

2,4,4-TRIMETHYL-2-PENTANOL, 95%, 200mg

3,5,6-Trimethylpyrazin-2(1H)-one, 95.0%, 250mg

trans-Ned 19, 99.53%, 100mg

Benzyl 3-ethyl-3-hydroxyazetidine-1-carboxylate, 95.0%, 250mg

2-Bromo-1-(bromomethyl)-4-nitrobenzene, 95.0%, 250mg

3-hydrazino-1-propanol, 95.0%, 250mg

Propan-2-amine hydrobromide, 97%, 5g

(3S)-3-(2,2-DIFLUOROETHYL)PYRROLIDINE HYDROCHLORIDE, 95%, 100mg

2-(1-Naphthylene)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece